default author photo

Esther Kissling

Epiconcept

Paris

France

SCHOLARLY PAPERS

7

DOWNLOADS

740

TOTAL CITATIONS

3

Scholarly Papers (7)

Actions:
Email selected abstracts
1.

Effectiveness of Covid-19 Vaccines Administered in the 2023 Autumnal Campaigns in Europe: Results from the Vebis Primary Care Test-Negative Design Study, September 2023–January 2024

Number of pages: 27 Posted: 01 May 2024
Charlotte Lanièce Delaunay, Aryse Melo, Marine Maurel, Clara Mazagatos, Luise Goerlitz, Joan O'Donnell, Beatrix Oroszi, Noémie Sève, Ana Paula Rodrigues, Iván Martínez-Baz, Adam Meijer, Ivan Mlinarić, Neus Latorre-Margalef, Mihaela Lazar, Gloria Pérez-Gimeno, Ralf Dürrwald, Charlene Bennett, Gergő Túri, Marie-Anne Rameix Welti, Raquel Guiomar, Jesús Castilla, Mariëtte Hooiveld, Sanja Kurečić Filipović, Tove Samuelsson Hagey, Frederika Dijkstra, Vítor Borges, Violeta Ramos Marín, Sabrina Bacci, Marlena Kaczmarek and Esther Kissling
Epiconcept, National Institute of Health Doutor Ricardo Jorge, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, Robert Koch Institute, Health Service Executive, Semmelweis University, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Croatian Institute of Public Health, Public Health Agency of Sweden, Romanian Institute of Science and Technology - National Institute of Research and Development for Microbiology and Immunology „Cantacuzino”, Carlos III Health Institute, Robert Koch Institute, University College Dublin (UCD), Semmelweis University, University of Paris-Saclay - Laboratoire de Microbiologie, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Instituto de Salud Pública y Laboral de Navarra, NIVEL (Netherlands Institute for Health Services Research), Croatian Institute of Public Health, Public Health Agency of Sweden, National Institute for Public Health and the Environment (RIVM), National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, Consejería de Sanidad, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 137 (534,155)
Citation 2

Abstract:

Loading...

COVID-19, vaccine effectiveness, multicentre study, test-negative design, Europe, SARS-CoV-2

2.

COVID-19 Vaccine Effectiveness Among Older Adults in 2025/26

Number of pages: 16 Posted: 12 Mar 2026 Last Revised: 20 Mar 2026
Charlotte Lanièce Delaunay, Alberto Mateo Urdiales, Gloria Pérez-Gimeno, Karen O’Reilly, Marina Uras, Annika Erdwiens, Ivan Mlinarić, Gergő Túri, Adam Meijer, Ana Paula Rodrigues, Mihaela Lazar, Neus Latorre-Margalef, Héloïse Lucaccioni, Nuno Verdasca, Antonino Bella, Maria Angeles Rafael de la Cruz Lopez, Eva Kelly, Vincent Enouf, Kristin Tolksdorf, Simona Puzelli, Ana Carmen Ibañez, Iván Martínez-Baz, Margaret Fitzgerald, Shirley Masse, Djin-Ye Oh, Marlena Kaczmarek, Sabrina Bacci and Esther Kissling
Epiconcept, Bruno Kessler Foundation, Carlos III Health Institute, Health Protection Surveillance Centre (HPSC), Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Robert Koch Institute - Department for Infectious Disease Epidemiology, Croatian Institute of Public Health, Semmelweis University, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Cantacuzino National Military Medical Institute for Research and Development, Public Health Agency of Sweden, Epiconcept, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Istituto Superiore di Sanità, The Directorate General of Public Health, The Health Service Executive-Health Protection Surveillance Centre (HSE-HPSC), University of Paris-Saclay - Institut Pasteur, Robert Koch Institute - Department for Infectious Disease Epidemiology, Istituto Superiore di Sanità - Department of Infectious Diseases, Consejería de Sanidad - Dirección General de Salud Pública, Instituto de Salud Pública y Laboral de Navarra, The Health Service Executive-Health Protection Surveillance Centre (HSE-HPSC), University of Corsica, Robert Koch Institute, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 114 (674,591)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Vaccine effectiveness, Europe

3.

The Potential Bias Introduced into COVID-19 Vaccine Effectiveness Studies at Primary Care Level Due to the Availability of SARS-CoV-2 Tests in the General Population

Number of pages: 28 Posted: 12 Nov 2024
Charlotte Lanièce Delaunay, Baltazar Nunes, Susana Monge, Marit de Lange, Gergő Túri, Ausenda Machado, Neus Latorre-Margalef, Ivan Mlinarić, Mihaela Lazar, Paloma Botella Rocamora, Annika Erdwiens, Noémie Sève, Lisa Domegan, Iván Martínez-Baz, Mariëtte Hooiveld, Beatrix Oroszi, Raquel Guiomar, Maike Sperk, Sanja Kurečić Filipović, Catalina Pascu, Juan Antonio Linares Dopido, Ralf Dürrwald, Marie-Anne Rameix-Welti, Adele McKenna, Jesús Castilla, Cheyenne van Hagen, Mirjam J. Knol, Sabrina Bacci, Marlena Kaczmarek and Esther Kissling
Epiconcept, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, National Institute for Public Health and the Environment (RIVM), Semmelweis University, National Institute of Health Doutor Ricardo Jorge, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute - Department for Infectious Disease Epidemiology, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Health Service Executive, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, NIVEL (Netherlands Institute for Health Services Research), Semmelweis University, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute, Université Paris Saclay, Health Service Executive, Instituto de Salud Pública y Laboral de Navarra, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 112 (630,858)
Citation 1

Abstract:

Loading...

COVID-19, Vaccine effectiveness, Test-negative design, Self-test, Bias, Directed acyclic graph, Simulation

4.

Primary Series COVID-19 Vaccine Effectiveness Among Health Care Workers in Albania, February–December 2021

Number of pages: 34 Posted: 07 Dec 2022
Julia Rubin-Smith, Madelyn Yiseth Rojas Castro, Iria Preza, Iris Hasibra, Jonilda Sulo, Albana Fico, Rovena Daja, Adela Vasili, Majlinda Kota, Alexis Schmid, Shela Sridhar, Alina Guseinova, Golubinka Boshevska, Gazmend Bejtja, Barbara Mühlemann, Pernille Jorgensen, Richard Pebody, Esther Kissling, Kathryn E. Lafond, Mark A. Katz and Silvia Bino
Harvard University - Global Health Program, Epiconcept, Government of Albania - Institute of Public Health, Government of Albania - Institute of Public Health, Southeast European Center for Surveillance and Control of Infectious Disease, Government of Albania - Institute of Public Health, Government of Albania - Institute of Public Health, Government of Albania - Institute of Public Health, Government of Albania - Institute of Public Health, Harvard University - Global Health Program, Harvard University - Global Health Program, World Health Organization (WHO) - World Health Organization Regional Office for Europe, World Health Organization (WHO) - World Health Organization Regional Office for Europe, World Health Organization (WHO) - World Health Organization Regional Office for Europe, Charité - Universitätsmedizin Berlin - Institute of Virology, World Health Organization (WHO) - World Health Organization Regional Office for Europe, World Health Organization (WHO) - World Health Organization Regional Office for Europe, Epiconcept, Government of the United States of America - Influenza Division, World Health Organization (WHO) - World Health Organization Regional Office for Europe and Government of Albania - Institute of Public Health
Downloads 110 (640,165)

Abstract:

Loading...

COVID-19, COVID-19 vaccine, vaccine effectiveness, hybrid immunity, SARS-CoV-2, healthcare workers, Albania, Delta variant

5.

COVID-19 Vaccine Effectiveness against Medically Attended Symptomatic SARS-CoV-2 Infection among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network

Number of pages: 20 Posted: 21 Mar 2025
Charlotte Lanièce Delaunay, Nuno Verdasca, Susana Monge, Lisa Domegan, Noémie Sève, Silke Buda, Adam Meijer, Héloïse Lucaccioni, Miriam López Torrijos, Adele McKenna, Vincent Enouf, Ralf Dürrwald, Eline In‘t Velt, Mª Ángel Valcárcel de Laiglesia, Charlene Bennett, Shirley Masse, Annika Erdwiens, Mariëtte Hooiveld, Ivan Mlinarić, Gergő Túri, Ana Paula Rodrigues, Iván Martínez-Baz, Mihaela Lazar, Neus Latorre-Margalef, Vítor Borges, Marlena Kaczmarek, Sabrina Bacci and Esther Kissling
Epiconcept, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Carlos III Institute of Health - Communicable Diseases Department, Health Protection Surveillance Centre (HPSC), Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Robert Koch Institute, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Epiconcept, Subdirección General de Epidemiología y Vigilancia de la Salud, Health Service Executive, University of Paris-Saclay - Institut Pasteur, Robert Koch Institute, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Murcia Regional Health Council-IMIB, University College Dublin (UCD), University of Corsica, Robert Koch Institute - Department for Infectious Disease Epidemiology, NIVEL (Netherlands Institute for Health Services Research), Croatian Institute of Public Health, Semmelweis University, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, Cantacuzino National Military Medical Institute for Research and Development, Public Health Agency of Sweden, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 108 (649,907)

Abstract:

Loading...

COVID-19, vaccine effectiveness, SARS-CoV-2, Europe

6.

Effectiveness of XBB.1.5 Vaccines against Symptomatic SARS-CoV-2 Infection in Older Adults during the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024

Number of pages: 17 Posted: 11 Jul 2024
Lore Merdrignac, Charlotte Lanièce Delaunay, Nuno Verdasca, Lorena Vega-Pirisc, Joan O’Donnell, Noémie Sève, Camino Trobajo-Sanmartín, Silke Buda, Mariëtte Hooiveld, Ana Paula Rodrigues, Gergő Túri, Neus Latorre-Margalef, Ivan Mlinarić, Mihaela Lazarm, Marine Maurel, Daniel Castrillejo, Charlene Bennett, Marie-Anne Rameix Welti, Iván Martínez-Baz, Ralf Dürrwald, Adam Meijer, Aryse Melo, Beatrix Oroszi, Tove Samuelsson Hagey, Sanja Kurečić Filipović, Frederika Dijkstra, Verónica Gomez, Sabrina Bacci, Marlena Kaczmarek and Esther Kissling
Epiconcept - Epidemiology Department, Epiconcept, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Carlos III Institute of Health, Health Protection Surveillance Centre (HPSC), Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, Robert Koch Institute, NIVEL (Netherlands Institute for Health Services Research), National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Semmelweis University, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Epiconcept, Consejería de Sanidad - Dirección General de Salud Pública, University College Dublin (UCD), University of Paris-Saclay - Laboratoire de Microbiologie, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, Robert Koch Institute, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute of Health Doutor Ricardo Jorge, Semmelweis University, Public Health Agency of Sweden, Croatian Institute of Public Health, National Institute for Public Health and the Environment (RIVM), National Institute of Health Doutor Ricardo Jorge, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 105 (664,543)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Vaccine effectiveness, Primary care, Case-control study, Test-negative design, Multi-country study

7.

Bbibp-Corv Vaccine Effectiveness Against Covid-19 in Patients Aged 60 Years and Older During the Delta-Dominant Period in the Federation of Bosnia and Herzegovina, a Test-Negative Case-Control Study

Number of pages: 22 Posted: 08 Feb 2024
Sanjin Musa, Lore Merdrignac, Sinisa Skocibusic, Rozalija Nedic, Seila Cilovic-Lagarija and Esther Kissling
Institute for Public Health of the Federation of Bosnia and Herzegovina, Epiconcept - Epidemiology Department, Institute for Public Health of the Federation of Bosnia and Herzegovina, Institute for Public Health of the Federation of Bosnia and Herzegovina, Institute for Public Health of the Federation of Bosnia and Herzegovina and Epiconcept
Downloads 54 (1,020,567)

Abstract:

Loading...

vaccine effectiveness, COVID-19, Sars-CoV-2, Delta variant, BBIBP-CorV, inactivated COVID-19 vaccines